Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States

Megan Dann Fesinmeyer, Roman Gulati, Steve Zeliadt, Noel Weiss, Alan R. Kristal, Ruth Etzioni

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Concurrent withincreasing prostate cancer incidence and declining prostate cancer mortality in the United States, the prevalence of obesity has been increasing steadily. Several studies have reported that obesity is associated with increased risk of high-grade prostate cancer and prostate cancer mortality, and it is thus likely that the increase in obesity has increased the burden of prostate cancer. In this study, we assess the potential effect of increasing obesity on prostate cancer incidence and mortality. We first estimate obesity-associated relative risks of low- and high-grade prostate cancer using data from the Prostate Cancer Prevention Trial. Then, using obesity prevalence data from the National Health and Nutrition Examination Survey and prostate cancer incidence data from the Surveillance, Epidemiology, and End Results program, we convert annual grade-specific prostate cancer incidence rates into incidence rates conditional on weight category. Next, we combine the conditional incidence rates withth e 1980 prevalence rates for each weight category to project annual grade-specific incidence under 1980 obesity levels. We use a simulation model based on observed survival and mortality data to translate the effects of obesity trends on prostate cancer incidence into effects on disease-specific mortality. The predicted increase in obesity prevalence since 1980 increased high-grade prostate cancer incidence by 15.5% and prostate cancer mortality by between 7.0% (under identical survival for obese and nonobese cases) and 23.0% (under different survival for obese and nonobese cases) in 2002. We conclude that increasing obesity prevalence since 1980 has partially obscured declines in prostate cancer mortality.

Original languageEnglish (US)
Pages (from-to)808-815
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number3
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Body Mass Index
Mortality
Incidence
Obesity
Population
SEER Program
Weights and Measures
Nutrition Surveys

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. / Fesinmeyer, Megan Dann; Gulati, Roman; Zeliadt, Steve; Weiss, Noel; Kristal, Alan R.; Etzioni, Ruth.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 3, 01.03.2009, p. 808-815.

Research output: Contribution to journalArticle

Fesinmeyer, Megan Dann ; Gulati, Roman ; Zeliadt, Steve ; Weiss, Noel ; Kristal, Alan R. ; Etzioni, Ruth. / Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 3. pp. 808-815.
@article{0477629ece744bf7a608cf3f78a0275f,
title = "Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States",
abstract = "Concurrent withincreasing prostate cancer incidence and declining prostate cancer mortality in the United States, the prevalence of obesity has been increasing steadily. Several studies have reported that obesity is associated with increased risk of high-grade prostate cancer and prostate cancer mortality, and it is thus likely that the increase in obesity has increased the burden of prostate cancer. In this study, we assess the potential effect of increasing obesity on prostate cancer incidence and mortality. We first estimate obesity-associated relative risks of low- and high-grade prostate cancer using data from the Prostate Cancer Prevention Trial. Then, using obesity prevalence data from the National Health and Nutrition Examination Survey and prostate cancer incidence data from the Surveillance, Epidemiology, and End Results program, we convert annual grade-specific prostate cancer incidence rates into incidence rates conditional on weight category. Next, we combine the conditional incidence rates withth e 1980 prevalence rates for each weight category to project annual grade-specific incidence under 1980 obesity levels. We use a simulation model based on observed survival and mortality data to translate the effects of obesity trends on prostate cancer incidence into effects on disease-specific mortality. The predicted increase in obesity prevalence since 1980 increased high-grade prostate cancer incidence by 15.5{\%} and prostate cancer mortality by between 7.0{\%} (under identical survival for obese and nonobese cases) and 23.0{\%} (under different survival for obese and nonobese cases) in 2002. We conclude that increasing obesity prevalence since 1980 has partially obscured declines in prostate cancer mortality.",
author = "Fesinmeyer, {Megan Dann} and Roman Gulati and Steve Zeliadt and Noel Weiss and Kristal, {Alan R.} and Ruth Etzioni",
year = "2009",
month = "3",
day = "1",
doi = "10.1158/1055-9965.EPI-08-0784",
language = "English (US)",
volume = "18",
pages = "808--815",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States

AU - Fesinmeyer, Megan Dann

AU - Gulati, Roman

AU - Zeliadt, Steve

AU - Weiss, Noel

AU - Kristal, Alan R.

AU - Etzioni, Ruth

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Concurrent withincreasing prostate cancer incidence and declining prostate cancer mortality in the United States, the prevalence of obesity has been increasing steadily. Several studies have reported that obesity is associated with increased risk of high-grade prostate cancer and prostate cancer mortality, and it is thus likely that the increase in obesity has increased the burden of prostate cancer. In this study, we assess the potential effect of increasing obesity on prostate cancer incidence and mortality. We first estimate obesity-associated relative risks of low- and high-grade prostate cancer using data from the Prostate Cancer Prevention Trial. Then, using obesity prevalence data from the National Health and Nutrition Examination Survey and prostate cancer incidence data from the Surveillance, Epidemiology, and End Results program, we convert annual grade-specific prostate cancer incidence rates into incidence rates conditional on weight category. Next, we combine the conditional incidence rates withth e 1980 prevalence rates for each weight category to project annual grade-specific incidence under 1980 obesity levels. We use a simulation model based on observed survival and mortality data to translate the effects of obesity trends on prostate cancer incidence into effects on disease-specific mortality. The predicted increase in obesity prevalence since 1980 increased high-grade prostate cancer incidence by 15.5% and prostate cancer mortality by between 7.0% (under identical survival for obese and nonobese cases) and 23.0% (under different survival for obese and nonobese cases) in 2002. We conclude that increasing obesity prevalence since 1980 has partially obscured declines in prostate cancer mortality.

AB - Concurrent withincreasing prostate cancer incidence and declining prostate cancer mortality in the United States, the prevalence of obesity has been increasing steadily. Several studies have reported that obesity is associated with increased risk of high-grade prostate cancer and prostate cancer mortality, and it is thus likely that the increase in obesity has increased the burden of prostate cancer. In this study, we assess the potential effect of increasing obesity on prostate cancer incidence and mortality. We first estimate obesity-associated relative risks of low- and high-grade prostate cancer using data from the Prostate Cancer Prevention Trial. Then, using obesity prevalence data from the National Health and Nutrition Examination Survey and prostate cancer incidence data from the Surveillance, Epidemiology, and End Results program, we convert annual grade-specific prostate cancer incidence rates into incidence rates conditional on weight category. Next, we combine the conditional incidence rates withth e 1980 prevalence rates for each weight category to project annual grade-specific incidence under 1980 obesity levels. We use a simulation model based on observed survival and mortality data to translate the effects of obesity trends on prostate cancer incidence into effects on disease-specific mortality. The predicted increase in obesity prevalence since 1980 increased high-grade prostate cancer incidence by 15.5% and prostate cancer mortality by between 7.0% (under identical survival for obese and nonobese cases) and 23.0% (under different survival for obese and nonobese cases) in 2002. We conclude that increasing obesity prevalence since 1980 has partially obscured declines in prostate cancer mortality.

UR - http://www.scopus.com/inward/record.url?scp=64549159838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549159838&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0784

DO - 10.1158/1055-9965.EPI-08-0784

M3 - Article

C2 - 19258479

AN - SCOPUS:64549159838

VL - 18

SP - 808

EP - 815

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -